Chemical Compound
methyl (13S,15S,17S)-13-((1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.0^(1,9).0^(2,7).0^(16,19))nonadeca-2(7),3,5,13-tetraen-4-yl)-17-ethyl-17-hydroxy-1,11-diazatetracyclo(13.3.1.0^(4,12).0^(5,10))nonadeca-4(12),5,7,9-tetraene-13-carboxylate
CAS Registry Number
53643-48-4
Primary record
methyl (13S,15S,17S)-13-((1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.0^(1,9).0^(2,7).0^(16,19))nonadeca-2(7),3,5,13-tetraen-4-yl)-17-ethyl-17-hydroxy-1,11-diazatetracyclo(13.3.1.0^(4,12).0^(5,10))nonadeca-4(12),5,7,9-tetraene-13-carboxylate
- 库存
- 6,520 克
- 纯度
- 99.3 %
- CAS
- 53643-48-4
化合物标识与属性
- CAS
- 53643-48-4
- PubChem CID
- 40839
- SMILES
- CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O
- Canonical SMILES
- CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
名称与同义词
- vindesine
- Vindesin
- Vindesina
- Vindesinum
- vindesine sulfate
- Eldesine
- Eldisine
- Desacetylvinblastine amide
- vindesin sulfate
- vindesin sulphate
- DAVA
- Vindesinum [INN-Latin]
- Vindesina [INN-Spanish]
- 53643-48-4
- Vindesine (USAN/INN)
- Lilly 112531
- Compound 112531
- Vindesine [USAN:BAN:INN]
- Compound 112531;
- Lilly CT-3231
- RefChem:901872
- UNII-RSA8KO39WH
- RSA8KO39WH
- Vindesine [USAN:INN:BAN]
- D04RLY
- COMPOUND-112531
- AC1L24KY
- SCHEMBL4420
- SCHEMBL4421
- C43H55N5O7
- DTXSID6023739
- CHEBI:36373
- HSDB 6961
- Deacetylvinblastine Carboxamide
- Desacetylvinblastine amide sulfate
- DESACETYLVINBLASTINEAMIDE
- HHJUWIANJFBDHT-KOTLKJBCSA-N
- DTXCID203739
- orb1684166
- Deacetyl Vinblastine Carboxamide
- SCHEMBL29550194
- EINECS 258-682-2
- L01CA03
- HMS2090E15
- CID40839
- EX-A3837
- ZINC8214470
- STL565153
- AKOS037623357
- C43-H55-N5-O7
- FS-7032
- NSC-245467
- AC-36879
- AN-40714
- HY-16514
- J24.547J
- 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine
- LS-162145
- 2181B
- NS00032802
- D06304
- Vincaleukoblastine, 3-(aminocarbonyl)-O4-deacetyl-3-de(methoxycarbonyl)-
- 15172-EP2269989A1
- 15172-EP2272827A1
- 15172-EP2272832A1
- 15172-EP2275420A1
- 15172-EP2281815A1
- 15172-EP2292615A1
- 15172-EP2295055A2
- 15172-EP2295416A2
- 15172-EP2295426A1
- 15172-EP2295427A1
- 15172-EP2298748A2
- 15172-EP2298764A1
- 15172-EP2298765A1
- 15172-EP2298768A1
- 15172-EP2298772A1
- 15172-EP2298778A1
- 15172-EP2301928A1
- 15172-EP2301933A1
- 15172-EP2305640A2
- 15172-EP2305642A2
- 15172-EP2305671A1
- 15172-EP2308833A2
- 15172-EP2308839A1
- 15172-EP2311453A1
- 15172-EP2311808A1
- 15172-EP2311825A1
- 15172-EP2311827A1
- 15172-EP2311829A1
- 15172-EP2311840A1
- 15172-EP2311842A2
- 15172-EP2316832A1
- 15172-EP2316833A1
- AB00698294-03
- AB01275494-01
- hanoazacycloundecino[5,4-b]indole-9-carboxylate
- 643V484
- Q416660
- 3-(aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine
- BRD-K59753975-001-02-6
- BRD-K59753975-065-01-3
- 3-(Aminocarbonyl)-O(sup 4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine
- 3-carbamoyl-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine
- Vincaleukoblastine, 23-amino-O(sup 4)-deacetyl-23-demethoxy-
- 3-Carbamoyl-4-O-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine
- 3-(Aminocarbonyl)-4-O-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine
- 3-(Aminocarbonyl)-O4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine
- 3-(Aminocarbonyl)-O4-deacetyl-3-de-(methoxycarbonyl)vincaleukoblastine
- 59917-39-4
- methyl (13S,15S,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
- methyl (5S,7S,9S)-9-[(2b,3b,4b,5a,12b,19a)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate
- methyl (5S,7S,9S)-9-[(2beta,3beta,4beta,5alpha,12beta,19alpha)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate
- Vincaleukoblastine, 3-(aminocarbonyl)-O(sup 4)-deacetyl-3-de(methoxycarbonyl)-
- 258-682-2
- DVA
- methyl (13S,15S,17S)-13-((1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.0^(1,9).0^(2,7).0^(16,19))nonadeca-2(7),3,5,13-tetraen-4-yl)-17-ethyl-17-hydroxy-1,11-diazatetracyclo(13.3.1.0^(4,12).0^(5,10))nonadeca-4(12),5,7,9-tetraene-13-carboxylate
- methyl (13S,15S,17S)-13-((1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.01,9.02,7.016,19)nonadeca-2,4,6,13-tetraen-4-yl)-17-ethyl-17-hydroxy-1,11-diazatetracyclo(13.3.1.04,12.05,10)nonadeca-4(12),5,7,9-tetraene-13-carboxylate
- methyl (13S,15S,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2(7),3,5,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.0^{4,12}.0^{5,10}]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
- methyl (13S,15S,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
- Methyl (3S,5S,7S,9S)-9-(3alpha-carbamoyl-3beta,4beta-dihydroxy-16-methoxy-1-methyl-2beta,5alpha,12beta,19alpha-6,7-didehydroaspidospermidin-15-yl)-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate
- methyl (5S,7S,9S)-9-[(2beta,3beta,4beta,5alpha,12beta,19alpha)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-met